Ileana Debre-Antony

Villejuif, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Unraveling the role of TP53 mutations in myeloproliferative neoplasms: Molecular mechanisms of leukemic transformation.

Unraveling the role of TP53 mutations in myeloproliferative neoplasms: Molecular mechanisms of leukemic transformation.

Journal: HemaSphere

Published: October 07, 2025

CAR T cell-mediated bone marrow inflammation causes hematotoxicity and favors clonal hematopoiesis.

CAR T cell-mediated bone marrow inflammation causes hematotoxicity and favors clonal hematopoiesis.

Journal: Science translational medicine

Published: September 24, 2025

DUSP6, a potential target to prevent leukemic progression in myeloproliferative neoplasms

DUSP6, a potential target to prevent leukemic progression in myeloproliferative neoplasms

Journal: Medecine sciences : M/S

Published: December 10, 2024

Clonal Evolution of PPM1D Mutations in the Spectrum of Myeloid Disorders.

Clonal Evolution of PPM1D Mutations in the Spectrum of Myeloid Disorders.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 04, 2024

Chromothripsis orchestrates leukemic transformation in blast phase MPN through targetable amplification of DYRK1A.

Chromothripsis orchestrates leukemic transformation in blast phase MPN through targetable amplification of DYRK1A.

Journal: bioRxiv : the preprint server for biology

Published: December 18, 2023

Chromothripsis-associated chromosome 21 amplification orchestrates transformation to blast-phase MPN through targetable overexpression of DYRK1A.

Chromothripsis-associated chromosome 21 amplification orchestrates transformation to blast-phase MPN through targetable overexpression of DYRK1A.

Journal: Nature genetics

Published: August 16, 2023

Deregulation of the p19/CDK4/CDK6 axis in Jak2V617F megakaryocytes accelerates the development of myelofibrosis.

Deregulation of the p19/CDK4/CDK6 axis in Jak2V617F megakaryocytes accelerates the development of myelofibrosis.

Journal: Leukemia

Published: June 30, 2023

The double-edged sword of adenosine.

The double-edged sword of adenosine.

Journal: Haematologica

Published: June 22, 2023

ANKRD26 is a new regulator of type I cytokine receptor signaling in normal and pathological hematopoiesis.

ANKRD26 is a new regulator of type I cytokine receptor signaling in normal and pathological hematopoiesis.

Journal: Haematologica

Published: September 05, 2022

Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution.

Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution.

Journal: Nature genetics

Published: February 18, 2022

Molecular Landscape of Therapy-related Myeloid Neoplasms in Patients Previously Treated for Gynecologic and Breast Cancers.

Molecular Landscape of Therapy-related Myeloid Neoplasms in Patients Previously Treated for Gynecologic and Breast Cancers.

Journal: HemaSphere

Published: May 03, 2021

Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights.

Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: March 29, 2021

Showing 1-12 of 28

Last Updated: 09/26/2026